The following is a summary of “Spaced Transcranial Direct Current Stimulation for Major Depression,” published in the January ...

There is no laboratory test for major depression, although physicians generally request tests for physical conditions that may cause similar symptoms. If depressive disorder is not detected in the ...

The depression treatment market is experiencing steady growth, driven by rising mental health awareness, increasing prevalence of depression, and advancements in novel therapies. The market is ...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a generative AI software leader in clinical trial analytics, announces its funded collaboration with ...

Following Pfizer’s acquisition, Biohaven’s valuation skyrocketed under Vlad Coric. Find out why BHVN stock’s growth potential ...

Ketamine can effectively treat depression, but whether depressed patients with alcohol use disorder can safely use ketamine ...

One in 20 U.S. adults experience seasonal depression, most often in winter. UVA professor Kim Penberthy shares self-care tips ...

Mice resilient to stress had more CB1 receptors in the BBB than mice with depressive-like behavior or mice not exposed to stress.

The factors that can trigger major depressive disorders; Pharmacological options when depression is not responding to first-line treatments; Pharmacological options for patients who need a ...

Objective This study aimed to investigate the incidence of overweight in patients with major depressive disorder (MDD) ...

Compass Pathways gains Stifel's Buy rating as its COMP360 psilocybin treatment advances in Phase 3 trials. Key depression study data expected in 2025-2026.